{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:37:31Z","timestamp":1792107451162,"version":"4.4.0"},"reference-count":275,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.lfs.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T03:03:30Z","timestamp":1557284610000},"page":"228-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"special_numbering":"C","title":["Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2004-3465","authenticated-orcid":false,"given":"Keywan","family":"Mortezaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6341-9007","authenticated-orcid":false,"given":"Masoud","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2290-7220","authenticated-orcid":false,"given":"Bagher","family":"Farhood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9737-3633","authenticated-orcid":false,"given":"Amirhossein","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaiza","family":"Potes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheyauldeen","family":"Shabeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Eleojo","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0005","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.lfs.2019.05.009_bb0010","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.19082\/3069","article-title":"A comparative study of cisplatin-based definitive chemo-radiation in non-metastatic squamous cell carcinoma of the esophagus","volume":"8","author":"Mofid","year":"2016","journal-title":"Electron. Physician"},{"issue":"suppl_9","key":"10.1016\/j.lfs.2019.05.009_bb0015","article-title":"436P identifying predictive factors for severe anemia in cancer patients treated with cytotoxic chemotherapy","volume":"29","author":"Mofid","year":"2018","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.lfs.2019.05.009_bb0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00066-014-0602-8","article-title":"Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy","volume":"190","author":"Razzaghdoust","year":"2014","journal-title":"Strahlenther. Onkol."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ptr.6230","article-title":"Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy","volume":"33","author":"Saadipoor","year":"2019","journal-title":"Phytother. Res."},{"issue":"12","key":"10.1016\/j.lfs.2019.05.009_bb0030","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jgm.452","article-title":"Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome","volume":"5","author":"Chapel","year":"2003","journal-title":"J. Gene Med."},{"issue":"8","key":"10.1016\/j.lfs.2019.05.009_bb0035","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/bjc.1998.618","article-title":"The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine","volume":"78","author":"Potten","year":"1998","journal-title":"Br. J. Cancer"},{"issue":"5965","key":"10.1016\/j.lfs.2019.05.009_bb0040","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1166202","article-title":"53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis","volume":"327","author":"Kirsch","year":"2010","journal-title":"science"},{"issue":"5528","key":"10.1016\/j.lfs.2019.05.009_bb0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.1060191","article-title":"Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice","volume":"293","author":"Paris","year":"2001","journal-title":"science"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1259\/bjr\/53186341","article-title":"The contribution of radiation-induced injury to the gastrointestinal tract in the development of multi-organ dysfunction syndrome or failure","author":"Monti","year":"2005","journal-title":"Br. J. Radiol."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1259\/bjr\/25654769","article-title":"Radiation-induced multi-organ involvement and failure: challenges for radiation accident medical management and future research","author":"Meineke","year":"2005","journal-title":"Br. J. Radiol."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ijrobp.2007.11.043","article-title":"Bax and Bak do not exhibit functional redundancy in mediating radiation-induced endothelial apoptosis in the intestinal mucosa","volume":"70","author":"Rotolo","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/SPC.0000000000000339","article-title":"Predicting mucositis risk associated with cytotoxic cancer treatment regimens: rationale, complexity, and challenges","volume":"12","author":"Bachour","year":"2018","journal-title":"Curr. Opin. Support. Palliat. Care"},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0070","article-title":"Evaluation of anticancer drug utilization and monitoring of adverse drug reaction in the indoor patients receiving cancer chemotherapy in a tertiary Care Hospital in New Delhi","volume":"9","author":"Aggarwal","year":"2018","journal-title":"J. Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0075","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpg.2016.06.001","article-title":"Management of radiation and chemotherapy related acute toxicity in gastrointestinal cancer","volume":"30","author":"Grabenbauer","year":"2016","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.lfs.2019.05.009_bb0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2017.12.011","article-title":"Role of drugs in the prevention and amelioration of radiation induced toxic effects","volume":"819","author":"Patyar","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0085","first-page":"36","article-title":"Radiation therapeutics and its acute effects on human body","volume":"5","author":"Upadhyay","year":"2017","journal-title":"J. Environ. Pollut. Hum. Health"},{"key":"10.1016\/j.lfs.2019.05.009_bb0090","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.biopha.2017.05.001","article-title":"Target\/signalling pathways of natural plant-derived radioprotective agents from treatment to potential candidates: a reverse thought on anti-tumour drugs","volume":"91","author":"Yun","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju403","article-title":"Induced phenotype targeted therapy: radiation-induced apoptosis-targeted chemotherapy","volume":"107","author":"Lee","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2019.05.009_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-med-081313-121208","article-title":"The DNA damage response: implications for tumor responses to radiation and chemotherapy","volume":"66","author":"Goldstein","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb0105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.lfs.2019.05.009_bb0110","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.nano.2015.07.013","article-title":"3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation","volume":"11","author":"Sethi","year":"2015","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb0115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"35","key":"10.1016\/j.lfs.2019.05.009_bb0120","doi-asserted-by":"crossref","first-page":"57077","DOI":"10.18632\/oncotarget.10976","article-title":"Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival","volume":"7","author":"Panza","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0125","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10495-008-0300-z","article-title":"Bcl2 family proteins in carcinogenesis and the treatment of cancer","volume":"14","author":"Frenzel","year":"2009","journal-title":"Apoptosis"},{"issue":"3b","key":"10.1016\/j.lfs.2019.05.009_bb0130","first-page":"2003","article-title":"Bcl-2 expression as a prognostic factor of survival of gastric carcinoma","volume":"18","author":"Inada","year":"1998","journal-title":"Anticancer Res."},{"issue":"7 Supplement","key":"10.1016\/j.lfs.2019.05.009_bb0135","first-page":"707","article-title":"Strong COX-2 overexpression in breast and prostate cancer - a potential therapeutic target","volume":"64","author":"Wild","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0140","first-page":"1393","article-title":"COX-2 overexpression increases motility and invasion of breast cancer cells","volume":"26","author":"Singh","year":"2005","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0145","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ccr.2013.03.022","article-title":"Mutant p53 prolongs NF-kappaB activation and promotes chronic inflammation and inflammation-associated colorectal cancer","volume":"23","author":"Cooks","year":"2013","journal-title":"Cancer Cell"},{"issue":"31","key":"10.1016\/j.lfs.2019.05.009_bb0150","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1038\/sj.onc.1204535","article-title":"Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis","volume":"20","author":"Huang","year":"2001","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ijc.11562","article-title":"NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells","volume":"108","author":"Xiong","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2019.05.009_bb0160","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2741\/3782","article-title":"NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target","volume":"16","author":"Chen","year":"2011","journal-title":"Front. Biosci."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/biomedicines5020029","article-title":"NF-\u03baB Signalling in Glioblastoma","volume":"5","author":"Soubannier","year":"2017","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0749.2006.00304.x","article-title":"NF-kappaB activation in melanoma","volume":"19","author":"Ueda","year":"2006","journal-title":"Pigment Cell Res."},{"issue":"12","key":"10.1016\/j.lfs.2019.05.009_bb0175","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/acm.2017.0081","article-title":"Beneficial effects of adjuvant melatonin in minimizing oral mucositis complications in head and neck cancer patients receiving concurrent chemoradiation","volume":"23","author":"Onseng","year":"2017","journal-title":"J. Altern. Complement. Med."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/01480545.2015.1055359","article-title":"Role of melatonin in mitigating chemotherapy-induced testicular dysfunction in Wistar rats","volume":"39","author":"Madhu","year":"2016","journal-title":"Drug Chem. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2019.05.009_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11010-017-3154-2","article-title":"Melatonin increases the effect of 5-fluorouracil-based chemotherapy in human colorectal adenocarcinoma cells in vitro","volume":"440","author":"Pariente","year":"2018","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0190","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00280-017-3441-3","article-title":"Participation of MT3 melatonin receptors in the synergistic effect of melatonin on cytotoxic and apoptotic actions evoked by chemotherapeutics","volume":"80","author":"Pariente","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jpi.12267","article-title":"Melatonin: an ancient molecule that makes oxygen metabolically tolerable","volume":"59","author":"Manchester","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb0200","first-page":"01","article-title":"Anti-inflammatory effects of melatonin: a mechanistic review","author":"Nabavi","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0205","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/10717544.2017.1338793","article-title":"Transdermal administration of melatonin coupled to cryopass laser treatment as noninvasive therapy for prostate cancer","volume":"24","author":"Terraneo","year":"2017","journal-title":"Drug Delivery"},{"issue":"10","key":"10.1016\/j.lfs.2019.05.009_bb0210","first-page":"5449","article-title":"Impressive suppression of colon cancer growth by triple combination SN38\/EF24\/melatonin:\u201concogenic\u201d versus \u201cOnco-suppressive\u201d reactive oxygen species","volume":"37","author":"Bakalova","year":"2017","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12967-015-0454-8","article-title":"Involvement of ROS-alpha v beta 3 integrin-FAK\/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia","volume":"13","author":"Xu","year":"2015","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12461","article-title":"Combination of melatonin and rapamycin for head and neck cancer therapy: suppression of AKT\/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation","volume":"64","author":"Shen","year":"2018","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0225","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrc1560","article-title":"The role of apoptosis in cancer development and treatment response","volume":"5","author":"Brown","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb0230","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","article-title":"Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis","volume":"45","author":"Ouyang","year":"2012","journal-title":"Cell Prolif."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0235","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169767","article-title":"Radiation induced apoptosis of murine bone marrow cells is independent of Early Growth Response 1 (EGR1)","volume":"12","author":"Oben","year":"2017","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.lfs.2019.05.009_bb0245","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1038\/sj.onc.1207494","article-title":"Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice","volume":"23","author":"Komarova","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2019.05.009_bb0250","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1038\/sj.onc.1202581","article-title":"Caspases: the proteases of the apoptotic pathway","volume":"17","author":"Nu\u00f1ez","year":"1999","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbpb.2008.05.010","article-title":"Caspases - an update","volume":"151","author":"Chowdhury","year":"2008","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"issue":"11","key":"10.1016\/j.lfs.2019.05.009_bb0260","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1745-7270.2005.00108.x","article-title":"Caspase family proteases and apoptosis","volume":"37","author":"Fan","year":"2005","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0265","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/ijms17060970","article-title":"Differential apoptosis Radiosensitivity of neural progenitors in adult mouse hippocampus","volume":"17","author":"Li","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2019.05.009_bb0270","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41420-018-0132-8","article-title":"Molecular and epigenetic regulatory mechanisms of normal stem cell radiosensitivity","volume":"4","author":"Fabbrizi","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2019.05.009_bb0275","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fonc.2012.00102","article-title":"Effects of ionizing radiation on the immune system with special emphasis on the interaction of dendritic and T cells","volume":"2","author":"Manda","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2019.05.009_bb0280","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fimmu.2017.00664","article-title":"Intercellular communication of tumor cells and immune cells after exposure to different ionizing radiation qualities","volume":"8","author":"Diegeler","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2019.05.009_bb0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fonc.2012.00191","article-title":"Radiation-induced effects and the immune system in cancer","volume":"2","author":"Kaur","year":"2012","journal-title":"Front. Oncol."},{"issue":"3b","key":"10.1016\/j.lfs.2019.05.009_bb0290","first-page":"2505","article-title":"Induction of apoptosis or necrosis by ionizing radiation is dose-dependent in MG-63 osteosarcoma multicellular spheroids","volume":"23","author":"Rainaldi","year":"2003","journal-title":"Anticancer Res."},{"issue":"11\u221212","key":"10.1016\/j.lfs.2019.05.009_bb0295","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00335-018-9777-0","article-title":"Radiation, inflammation and the immune response in cancer","volume":"29","author":"McKelvey","year":"2018","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.lfs.2019.05.009_bb0300","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1038\/ncomms4494","article-title":"Ionizing irradiation induces acute haematopoietic syndrome and gastrointestinal syndrome independently in mice","volume":"5","author":"Leibowitz","year":"2014","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0305","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/1541-7786.MCR-11-0052","article-title":"Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21","volume":"9","author":"Leibowitz","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb0310","first-page":"163","article-title":"P9. Correlation of radiation induced apoptosis with Bax and Bcl-2 protein expression. Physica Medica","volume":"32","author":"Sogwagwa","year":"2016","journal-title":"Eur. J. Med. Phys. Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/B978-0-12-417158-9.00005-4","article-title":"Apoptosis initiation through the cell-extrinsic pathway","volume":"544","author":"Nair","year":"2014","journal-title":"Methods Enzymol."},{"issue":"20","key":"10.1016\/j.lfs.2019.05.009_bb0320","first-page":"5754","article-title":"Apo2 ligand\/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells","volume":"60","author":"Gong","year":"2000","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00130404-200607000-00004","article-title":"The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L\/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death","volume":"12","author":"Nguyen","year":"2006","journal-title":"Cancer J."},{"key":"10.1016\/j.lfs.2019.05.009_bb0330","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-cellbio-100913-013226","article-title":"Regulated cell death: signaling and mechanisms","volume":"30","author":"Ashkenazi","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0335","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/oxfordjournals.bmb.a011629","article-title":"Ceramide signaling in apoptosis","volume":"53","author":"Haimovitz-Friedman","year":"1997","journal-title":"Br. Med. Bull."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0340","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0006-2952(96)00834-9","article-title":"Stress-induced apoptosis and the sphingomyelin pathway","volume":"53","author":"Pena","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2019.05.009_bb0345","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/cdd.2014.128","article-title":"Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling","volume":"22","author":"Yabu","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2019.05.009_bb0350","series-title":"Bioactive Sphingolipids in Cancer Biology and Therapy","first-page":"259","article-title":"The role and function of sphingolipids in glioblastoma Multiforme","author":"Abdel Hadi","year":"2015"},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0355","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.3390\/ijms16035076","article-title":"Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate","volume":"16","author":"Ueda","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"4 Suppl","key":"10.1016\/j.lfs.2019.05.009_bb0360","doi-asserted-by":"crossref","first-page":"N87","DOI":"10.1097\/00003246-200004001-00010","article-title":"Ceramide mediates radiation-induced death of endothelium","volume":"28","author":"Lin","year":"2000","journal-title":"Crit. Care Med."},{"issue":"37","key":"10.1016\/j.lfs.2019.05.009_bb0365","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1038\/sj.onc.1206702","article-title":"Radiation and ceramide-induced apoptosis","volume":"22","author":"Kolesnick","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2019.05.009_bb0370","first-page":"85","article-title":"Signaling in and regulation of ionizing radiation-induced apoptosis in endothelial cells","volume":"53","author":"Billis","year":"1998","journal-title":"Recent Prog. Horm. Res."},{"issue":"9\u201310","key":"10.1016\/j.lfs.2019.05.009_bb0375","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1947601913485414","article-title":"Mitogen-activated protein kinases and their role in radiation response","volume":"4","author":"Munshi","year":"2013","journal-title":"Genes Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb0380","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1054\/drup.2001.0225","article-title":"Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance","volume":"4","author":"Ogretmen","year":"2001","journal-title":"Drug Resist. Updat."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0385","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2003.08.034","article-title":"Ceramide synthesis and metabolism as a target for cancer therapy","volume":"206","author":"Reynolds","year":"2004","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0390","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/157489211796957838","article-title":"Ceramide in chemotherapy of tumors","volume":"6","author":"Dimanche-Boitrel","year":"2011","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.02.020","article-title":"Ceramide-induced cell death in malignant cells","volume":"264","author":"Carpinteiro","year":"2008","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0400","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/1535-7163.MCT-05-0420","article-title":"Sphingolipid targets in cancer therapy","volume":"5","author":"Modrak","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0405","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.3390\/ijms14048638","article-title":"Melatonin: buffering the immune system","volume":"14","author":"Carrillo-Vico","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0410","first-page":"423","article-title":"The modulatory role of melatonin on immune responsiveness","volume":"7","author":"Carrillo-Vico","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"16","key":"10.1016\/j.lfs.2019.05.009_bb0415","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","article-title":"Extrapineal melatonin: sources, regulation, and potential functions","volume":"71","author":"Acu\u00f1a-Castroviejo","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"16","key":"10.1016\/j.lfs.2019.05.009_bb0420","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","article-title":"Extrapineal melatonin: sources, regulation, and potential functions","volume":"71","author":"Acuna-Castroviejo","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.lfs.2019.05.009_bb0425","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/nu10091135","article-title":"Dietary melatonin supplementation could be a promising preventing\/therapeutic approach for a variety of liver diseases","volume":"10","author":"Bonomini","year":"2018","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0430","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3390\/ijms19051528","article-title":"Melatonin: a multifunctional factor in plants","volume":"19","author":"Fan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2019.05.009_bb0435","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","article-title":"MT1 and MT2 melatonin receptors: a therapeutic perspective","volume":"56","author":"Liu","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0440","first-page":"801","article-title":"Melatonin synergizes the chemotherapeutic effect of cisplatin in ovarian Cancer cells independently of MT1 melatonin receptors","volume":"31","author":"Zem\u0142a","year":"2017","journal-title":"In Vivo"},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0445","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jpi.12032","article-title":"Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma","volume":"54","author":"Jablonska","year":"2013","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0450","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1525-1373.2000.22502.x","article-title":"Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation","volume":"225","author":"Karbownik","year":"2000","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0455","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1269\/jrr.46.277","article-title":"Radioprotective effects of melatonin on radiation-induced cataract","volume":"46","author":"Karslioglu","year":"2005","journal-title":"J. Radiat. Res."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0460","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/09553002.2013.734943","article-title":"Melatonin reduces X-ray radiation-induced lung injury in mice by modulating oxidative stress and cytokine expression","volume":"89","author":"Jang","year":"2013","journal-title":"Int. J. Radiat. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0465","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1667\/3034","article-title":"The effect of melatonin against oxidative damage during total-body irradiation in rats","volume":"160","author":"Koc","year":"2003","journal-title":"Radiat. Res."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0470","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ecoenv.2006.03.008","article-title":"Ameliorative effect of melatonin against gamma-irradiation-induced oxidative stress and tissue injury","volume":"66","author":"El-Missiry","year":"2007","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0475","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1525-1373.2000.22502.x","article-title":"Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation","volume":"225","author":"Karbownik","year":"2000","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174474","article-title":"Melatonin protects rats from radiotherapy-induced small intestine toxicity","volume":"12","author":"Fernandez-Gil","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0485","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0923-1811(01)00088-3","article-title":"Melatonin reduces X-ray irradiation-induced oxidative damages in cultured human skin fibroblasts","volume":"26","author":"Chun Kim","year":"2001","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0490","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-079X.2007.00507.x","article-title":"Melatonin mitigates oxidative damage and apoptosis in mouse cerebellum induced by high-LET 56Fe particle irradiation","volume":"44","author":"Manda","year":"2008","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0495","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10620-012-2437-4","article-title":"Preclinical efficacy of melatonin to reduce methotrexate-induced oxidative stress and small intestinal damage in rats","volume":"58","author":"Kolli","year":"2013","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0500","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jat.1276","article-title":"Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy","volume":"28","author":"Qin","year":"2008","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.lfs.2019.05.009_bb0505","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1439-0272.2011.01269.x","article-title":"Melatonin attenuates doxorubicin-induced testicular toxicity in rats","volume":"44","author":"Lee","year":"2012","journal-title":"Andrologia"},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0510","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0960327113489052","article-title":"Melatonin ameliorates oxidative stress and reproductive toxicity induced by cyclophosphamide in male mice","volume":"33","author":"Chabra","year":"2014","journal-title":"Hum. Exp. Toxicol."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0515","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cbf.1676","article-title":"Melatonin attenuates methotrexate-induced oxidative stress and renal damage in rats","volume":"28","author":"Abraham","year":"2010","journal-title":"Cell Biochem. Funct."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0520","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jphp.12855","article-title":"The role of melatonin on chemotherapy-induced reproductive toxicity","volume":"70","author":"Haghi-Aminjan","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0525","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/carcin\/bgt025","article-title":"Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation","volume":"34","author":"Santoro","year":"2013","journal-title":"Carcinogenesis"},{"issue":"24","key":"10.1016\/j.lfs.2019.05.009_bb0530","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/onc.2011.469","article-title":"Melatonin triggers p53 Ser phosphorylation and prevents DNA damage accumulation","volume":"31","author":"Santoro","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0535","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12416","article-title":"Melatonin: a pleiotropic molecule that modulates DNA damage response and repair pathways","volume":"63","author":"Majidinia","year":"2017","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb0540","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1590\/1414-431X20122230","article-title":"Effects of melatonin on DNA damage induced by cyclophosphamide in rats","volume":"46","author":"Ferreira","year":"2013","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0545","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-7992(95)90065-9","article-title":"Melatonin protects human blood lymphocytes from radiation-induced chromosome damage","volume":"346","author":"Vijayalaxmi","year":"1995","journal-title":"Mutat. Res."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0550","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0027-5107(97)00211-X","article-title":"Melatonin reduces gamma radiation-induced primary DNA damage in human blood lymphocytes","volume":"397","author":"Vijayalaxmi","year":"1998","journal-title":"Mutat. Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0555","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12094-018-1934-0","article-title":"Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization","volume":"21","author":"Farhood","year":"2019","journal-title":"Clin. Transl. Oncol."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0560","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/tox.22254","article-title":"Melatonin attenuates 60Co \u03b3-ray-induced hematopoietic, immunological and gastrointestinal injuries in C57BL\/6 male mice","volume":"32","author":"Khan","year":"2017","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0565","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12929-015-0156-9","article-title":"Radioprotective potential of melatonin against 60 co \u03b3-ray-induced testicular injury in male C57BL\/6 mice","volume":"22","author":"Khan","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2019.05.009_bb0570","series-title":"The Effect of Melatonin on Cisplatin Induced-Kidney Injury in Rats: Possible Role of Autophagy","author":"TORK","year":"2013"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0575","first-page":"1015","article-title":"The role of melatonin and melatonin receptors in pharmacology and pharmacotherapy of cancer","volume":"2","author":"Ataee","year":"2017","journal-title":"Austin Oncol."},{"issue":"9","key":"10.1016\/j.lfs.2019.05.009_bb0580","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/17425255.2018.1513492","article-title":"The protective role of melatonin in chemotherapy-induced nephrotoxicity: a systematic review of non-clinical studies","volume":"14","author":"Haghi-Aminjan","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb0585","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/biolre\/iox053","article-title":"Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity","volume":"96","author":"Barberino","year":"2017","journal-title":"Biol. Reprod."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0590","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MOO.0b013e3282eee452","article-title":"Mechanisms of cisplatin ototoxicity and progress in otoprotection","volume":"15","author":"Rybak","year":"2007","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.lfs.2019.05.009_bb0595","first-page":"8","article-title":"The potential use of melatonin for preventing cisplatin ototoxicity: an insight for a clinical approach","volume":"2014","author":"Gusm","year":"2014","journal-title":"Adv. Otorhinolaryngol."},{"issue":"9","key":"10.1016\/j.lfs.2019.05.009_bb0600","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/15384047.2017.1360442","article-title":"Radiotherapy induces cell cycle arrest and cell apoptosis in nasopharyngeal carcinoma via the ATM and Smad pathways","volume":"18","author":"Li","year":"2017","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0605","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13014-015-0474-9","article-title":"Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer","volume":"10","author":"Zerp","year":"2015","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0610","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semradonc.2014.07.005","article-title":"Radiotherapy and immunogenic cell death","volume":"25","author":"Golden","year":"2015","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.lfs.2019.05.009_bb0615","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fonc.2016.00141","article-title":"Modern radiotherapy concepts and the impact of radiation on immune activation","volume":"6","author":"Deloch","year":"2016","journal-title":"Front. Oncol."},{"issue":"24","key":"10.1016\/j.lfs.2019.05.009_bb0620","doi-asserted-by":"crossref","first-page":"39896","DOI":"10.18632\/oncotarget.16379","article-title":"Melatonin for the prevention and treatment of cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0625","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/ijms18040843","article-title":"Melatonin, a full service anti-Cancer agent: inhibition of initiation, progression and metastasis","volume":"18","author":"Reiter","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0630","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-079X.2008.00585.x","article-title":"Critical role of glutathione in melatonin enhancement of tumor necrosis factor and ionizing radiation-induced apoptosis in prostate cancer cells in vitro","volume":"45","author":"Sainz","year":"2008","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb0635","doi-asserted-by":"crossref","unstructured":"O'Connell J. Fas ligand and the fate of antitumour cytotoxic T lymphocytes. Immunology, 2002, 105(3): 263\u20136.","DOI":"10.1046\/j.1365-2567.2002.01379.x"},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb0640","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.lfs.2019.05.009_bb0645","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/cncr.20270","article-title":"The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy","volume":"100","author":"Kim","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2019.05.009_bb0650","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.cgt.7701008","article-title":"The effects of FasL on inflammation and tumor survival are dependent on its expression levels","volume":"14","author":"Wada","year":"2006","journal-title":"Cancer Gene Ther."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0655","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1054\/drup.2001.0210","article-title":"The role of Fas and FasL as mediators of anticancer chemotherapy","volume":"4","author":"Poulaki","year":"2001","journal-title":"Drug Resist. Updat."},{"issue":"16","key":"10.1016\/j.lfs.2019.05.009_bb0660","first-page":"3331","article-title":"Drug-induced apoptosis is associated with enhanced Fas (Apo-1\/CD95) ligand expression but occurs independently of Fas (Apo-1\/CD95) signaling in human T-acute lymphatic leukemia cells","volume":"57","author":"Villunger","year":"1997","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.lfs.2019.05.009_bb0665","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/jnci\/91.19.1678","article-title":"Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors","volume":"91","author":"Mitsiades","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb0670","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1517\/13543784.10.6.1075","article-title":"Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug","volume":"10","author":"Mitsiades","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb0675","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.4049\/jimmunol.0902961","article-title":"Melatonin protects CD4+ T cells from activation-induced cell death by blocking NFAT-mediated CD95 ligand upregulation","volume":"184","author":"Pedrosa","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0680","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-079X.2009.00727.x","article-title":"Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway","volume":"48","author":"Casado-Zapico","year":"2010","journal-title":"J. Pineal Res."},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb0685","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjc.2012.66","article-title":"Fas\/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin","volume":"106","author":"Garc\u00eda-Santos","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0690","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-079X.2010.00850.x","article-title":"Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients","volume":"50","author":"Casado-Zapico","year":"2011","journal-title":"J. Pineal Res."},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb0695","first-page":"1391","article-title":"Apoptosis, p53, and tumor cell sensitivity to anticancer agents","volume":"59","author":"Brown","year":"1999","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0700","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s002800050861","article-title":"The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines","volume":"43","author":"Yamamoto","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0705","first-page":"807","article-title":"Expression of p53 protein as a predictor of the response to 5-fluorouracil and cisplatin chemotherapy in human gastrointestinal cancer cell lines evaluated with apoptosis by use of thin layer collagen gel","volume":"24","author":"Matsuhashi","year":"2004","journal-title":"Int. J. Oncol."},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb0710","first-page":"1391","article-title":"Apoptosis, p53, and tumor cell sensitivity to anticancer agents","volume":"59","author":"Brown","year":"1999","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0715","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000123851","article-title":"TP53 status and response to chemotherapy in breast cancer","volume":"75","author":"Bertheau","year":"2008","journal-title":"Pathobiology"},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0720","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4161\/cc.28108","article-title":"Revisiting p53 for cancer-specific chemo- and radiotherapy: ten years after","volume":"13","author":"Beckta","year":"2014","journal-title":"Cell Cycle"},{"issue":"24","key":"10.1016\/j.lfs.2019.05.009_bb0725","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.4161\/cc.22852","article-title":"p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3","volume":"11","author":"Chappell","year":"2012","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0730","first-page":"165","article-title":"p53 gene status and chemosensitivity in ovarian cancer","volume":"14","author":"Kigawa","year":"2001","journal-title":"Hum. Cell"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0735","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41467-017-02097-9","article-title":"PEPD is a pivotal regulator of p53 tumor suppressor","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0740","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.18632\/oncotarget.13475","article-title":"The role of p53 in cancer drug resistance and targeted chemotherapy","volume":"8","author":"Hientz","year":"2016","journal-title":"Oncotarget"},{"issue":"3\u20134","key":"10.1016\/j.lfs.2019.05.009_bb0745","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1947601912455199","article-title":"Dual roles of MDM2 in the regulation of p53: ubiquitination dependent and ubiquitination independent mechanisms of MDM2 repression of p53 activity","volume":"3","author":"Shi","year":"2012","journal-title":"Genes Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0750","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2006.01.020","article-title":"p53 ubiquitination: Mdm2 and beyond","volume":"21","author":"Brooks","year":"2006","journal-title":"Mol. Cell"},{"issue":"45","key":"10.1016\/j.lfs.2019.05.009_bb0755","first-page":"145","article-title":"The role of p53 in apoptosis","volume":"9","author":"Amaral","year":"2010","journal-title":"Discov. Med."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0760","first-page":"16","article-title":"Differential effect of selected methylxanthine derivatives on radiosensitization of lung carcinoma cells","volume":"28","author":"Malki","year":"2006","journal-title":"Exp. Oncol."},{"issue":"20","key":"10.1016\/j.lfs.2019.05.009_bb0765","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1242\/jcs.00739","article-title":"Apoptosis - the p53 network","volume":"116","author":"Haupt","year":"2003","journal-title":"J. Cell Sci."},{"issue":"10","key":"10.1016\/j.lfs.2019.05.009_bb0770","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1074\/jbc.275.10.7337","article-title":"p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release","volume":"275","author":"Schuler","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb0775","first-page":"1799","article-title":"Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo","volume":"9","author":"Miyashita","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2019.05.009_bb0780","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","article-title":"Control of apoptosis by p53","volume":"22","author":"Fridman","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0785","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2015.10.015","article-title":"Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis","volume":"370","author":"Alonso-Gonzalez","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2019.05.009_bb0790","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.biopha.2016.07.004","article-title":"Melatonin promotes ATO-induced apoptosis in MCF-7 cells: proposing novel therapeutic potential for breast cancer","volume":"83","author":"Nooshinfar","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0795","first-page":"560","article-title":"Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF7 human breast cancer cells","volume":"52","author":"Alonso-Gonzalez","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0800","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5483\/BMBRep.2008.41.1.011","article-title":"The role of mitochondria in apoptosis","volume":"41","author":"Jeong","year":"2008","journal-title":"BMB Rep."},{"key":"10.1016\/j.lfs.2019.05.009_bb0805","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis","volume":"43","author":"Wang","year":"2009","journal-title":"Annu. Rev. Genet."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0810","first-page":"25","article-title":"Apoptosis: a mitochondrial perspective on cell death","volume":"43","author":"Mishra","year":"2005","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.lfs.2019.05.009_bb0815","series-title":"Ueber den stoffwechsel der tumoren","author":"Warburg","year":"1926"},{"issue":"19","key":"10.1016\/j.lfs.2019.05.009_bb0820","doi-asserted-by":"crossref","first-page":"17081","DOI":"10.18632\/oncotarget.4012","article-title":"Melatonin antiproliferative effects require active mitochondrial function in embryonal carcinoma cells","volume":"6","author":"Loureiro","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0825","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/taap.2000.9115","article-title":"Disruption of mitochondrial respiration by melatonin in MCF-7 cells","volume":"171","author":"Scott","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"24","key":"10.1016\/j.lfs.2019.05.009_bb0830","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.3760\/cma.j.issn.0366-6999.20131965","article-title":"Elevated levels of mitochonrial respiratory complexes activities and ATP production in 17-beta-estradiol-induced prolactin-secretory tumor cells in male rats are inhibited by melatonin in vivo and in vitro","volume":"126","author":"Wang","year":"2013","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.lfs.2019.05.009_bb0835","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7187128","article-title":"Melatonin enhances cisplatin and radiation cytotoxicity in head and neck squamous cell carcinoma by stimulating mitochondrial ROS generation, apoptosis, and autophagy","volume":"2019","author":"Fernandez-Gil","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0840","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4254\/wjh.v6.i4.230","article-title":"Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions","volume":"6","author":"Bennukul","year":"2014","journal-title":"World J. Hepatol."},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb0845","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.21873\/anticanres.12681","article-title":"Melatonin promotes apoptosis of colorectal Cancer cells via superoxide-mediated ER stress by inhibiting cellular prion protein expression","volume":"38","author":"YUN","year":"2018","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0850","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12478","article-title":"Mitochondrial cytochrome P450 (CYP) 1B1 is responsible for melatonin-induced apoptosis in neural cancer cells","volume":"65","author":"Yu","year":"2018","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0855","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-079X.2012.00974.x","article-title":"Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells","volume":"53","author":"Uguz","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb0860","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40170-015-0130-8","article-title":"Mitophagy and cancer","volume":"3","author":"Chourasia","year":"2015","journal-title":"Cancer Metab."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0865","first-page":"617","article-title":"Dual role of mitophagy in cancer drug resistance","volume":"38","author":"Yan","year":"2018","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0870","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12461","article-title":"Combination of melatonin and rapamycin for head and neck cancer therapy: suppression of AKT\/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation","volume":"64","author":"Shen","year":"2018","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0875","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/jpi.12358","article-title":"Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy","volume":"61","author":"Prieto-Dominguez","year":"2016","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb0880","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12935-019-0777-2","article-title":"Melatonin enhances TNF-alpha-mediated cervical cancer HeLa cells death via suppressing CaMKII\/Parkin\/mitophagy axis","volume":"19","author":"Zhao","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb0885","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41418-018-0086-7","article-title":"Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2alpha-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy","volume":"25","author":"Zhou","year":"2018","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11626-017-0200-z","article-title":"Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK\/Parkin\/mitophagy axis","volume":"54","author":"Chen","year":"2018","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"16","key":"10.1016\/j.lfs.2019.05.009_bb0895","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1128\/MCB.21.16.5299-5305.2001","article-title":"NF-kappaB signals induce the expression of c-FLIP","volume":"21","author":"Micheau","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0900","first-page":"1059","article-title":"Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling","volume":"63","author":"Chen","year":"2003","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0905","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","article-title":"Mechanisms of caspase activation and inhibition during apoptosis","volume":"9","author":"Shi","year":"2002","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.lfs.2019.05.009_bb0910","first-page":"387","article-title":"Modulating Survivin as a Radioresistant factor, Caspase-3, and apoptosis by Omega-3 docosahexaenoic acid sensitizes mutant-p53 colorectal Cancer cells to gamma-irradiation","volume":"33","author":"Hosseini","year":"2018","journal-title":"Cancer Biother. Radiopharm."},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb0915","first-page":"2721","article-title":"NIK and IKKbetabinding protein contributes to gastric cancer chemoresistance by promoting epithelialmesenchymal transition through the NFkappaB signaling pathway","volume":"39","author":"Fu","year":"2018","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.lfs.2019.05.009_bb0920","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045078","article-title":"ER stress activates NF-\u03baB by integrating functions of basal IKK activity, IRE1 and PERK","volume":"7","author":"Tam","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0925","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1158\/0008-5472.CAN-12-3212","article-title":"Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4","volume":"73","author":"Burikhanov","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0930","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41420-017-0012-7","article-title":"Modulation of nuclear factor-kappa B activation by the endoplasmic reticulum stress sensor PERK to mediate estrogen-induced apoptosis in breast cancer cells","volume":"4","author":"Fan","year":"2018","journal-title":"Cell Death Dis."},{"issue":"22","key":"10.1016\/j.lfs.2019.05.009_bb0935","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/sj.onc.1204343","article-title":"Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines","volume":"20","author":"Bentires-Alj","year":"2001","journal-title":"Oncogene"},{"issue":"1_supplement","key":"10.1016\/j.lfs.2019.05.009_bb0940","article-title":"Antitumoral effect of melatonin by G-protein mediated toll-like receptor (TLR) activation through autophagic cell death in gynecologic cancer cells","volume":"23","author":"Hong","year":"2009","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb0945","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12885-015-1032-4","article-title":"Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer","volume":"15","author":"Chuffa","year":"2015","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0950","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/jpi.12035","article-title":"Melatonin potentiates the antiproliferative and pro-apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways","volume":"54","author":"Wang","year":"2013","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb0955","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12380","article-title":"Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K\/AKT and NF-\u03baB\/iNOS signaling pathways","volume":"62","author":"Gao","year":"2017","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb0960","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.redox.2018.02.025","article-title":"Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS","volume":"16","author":"Zou","year":"2018","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb0965","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1002\/jcp.27391","article-title":"Melatonin and cancer: from the promotion of genomic stability to use in cancer treatment","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb0970","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12094-018-1934-0","article-title":"Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization","volume":"21","author":"Farhood","year":"2019","journal-title":"Clin. Transl. Oncol."},{"issue":"12","key":"10.1016\/j.lfs.2019.05.009_bb0975","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.2174\/1871520618666180131112304","article-title":"Melatonin differentially modulates NF-capital KA, CyrillicB expression in breast and liver cancer cells","volume":"18","author":"Colombo","year":"2018","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb0980","first-page":"2221","article-title":"Melatonin inhibits epithelialtomesenchymal transition in gastric cancer cells via attenuation of IL1beta\/NFkappaB\/MMP2\/MMP9 signaling","volume":"42","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"22","key":"10.1016\/j.lfs.2019.05.009_bb0985","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/cncr.28864","article-title":"The MAPK pathway across different malignancies: a new perspective","volume":"120","author":"Burotto","year":"2014","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.lfs.2019.05.009_bb0990","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1158\/1078-0432.CCR-13-1081","article-title":"Molecular pathways: adaptive kinome reprogramming in response to targeted inhibition of the BRAF-MEK-ERK pathway in cancer","volume":"20","author":"Johnson","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb0995","doi-asserted-by":"crossref","unstructured":"Poulikakos PI and Solit DB. Resistance to MEK inhibitors: should we co-target upstream? Sci. Signal., 2011, 4(166): pe16.","DOI":"10.1126\/scisignal.2001948"},{"issue":"22","key":"10.1016\/j.lfs.2019.05.009_bb1000","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb1005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1078-0432.CCR-07-4790","article-title":"Advances in targeting the Ras\/Raf\/MEK\/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy","volume":"14","author":"Friday","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb1010","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3892\/or.2014.3295","article-title":"S-allylmercaptocysteine promotes MAPK inhibitor-induced apoptosis by activating the TGF-beta signaling pathway in cancer cells","volume":"32","author":"Tong","year":"2014","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.lfs.2019.05.009_bb1015","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1535-7163.MCT-17-0456","article-title":"Targeting the MAPK signaling pathway in Cancer: promising preclinical activity with the novel selective ERK1\/2 inhibitor BVD-523 (Ulixertinib)","volume":"16","author":"Germann","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb1020","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1535-7163.MCT-15-0496","article-title":"Concomitant inhibition of PI3Kbeta and BRAF or MEK in PTEN-deficient\/BRAF-mutant melanoma treatment: preclinical assessment of SAR260301 oral PI3Kbeta-selective inhibitor","volume":"15","author":"Bonnevaux","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2019.05.009_bb1025","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb1030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171157","article-title":"Inhibition of NF-\u03baB pathway and modulation of MAPK signaling pathways in glioblastoma and implications for lovastatin and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) combination therapy","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb1035","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1074\/jbc.M507951200","article-title":"The involvement of MAPK signaling pathways in determining the cellular response to p53 activation: cell cycle arrest or apoptosis","volume":"281","author":"Brown","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb1040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/0929867320666131119155023","article-title":"P38 MAPK contributes to resistance and invasiveness of HER2- overexpressing breast cancer","volume":"21","author":"Donnelly","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2019.05.009_bb1045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2407-8-375","article-title":"Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells","volume":"8","author":"Guo","year":"2008","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb1050","first-page":"7241","article-title":"p38 predicts depression and poor outcome in esophageal cancer","volume":"14","author":"Cheng","year":"2017","journal-title":"Oncol. Lett."},{"issue":"69","key":"10.1016\/j.lfs.2019.05.009_bb1055","doi-asserted-by":"crossref","first-page":"113331","DOI":"10.18632\/oncotarget.22970","article-title":"MAEL contributes to gastric cancer progression by promoting ILKAP degradation","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb1060","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1471-4159.2004.02514.x","article-title":"In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus","volume":"90","author":"Anhe","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2019.05.009_bb1065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphar.2012.00113","article-title":"Cancer therapy targeting the HER2-PI3K pathway: potential impact on the heart","volume":"3","author":"Klement","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb1070","doi-asserted-by":"crossref","first-page":"e92627","DOI":"10.1371\/journal.pone.0092627","article-title":"Melatonin combined with endoplasmic reticulum stress induces cell death via the PI3K\/Akt\/mTOR pathway in B16F10 melanoma cells","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.lfs.2019.05.009_bb1075","doi-asserted-by":"crossref","first-page":"24435","DOI":"10.1074\/jbc.M801738200","article-title":"Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells","volume":"283","author":"Mamillapalli","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb1080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4196\/kjpp.2008.12.2.37","article-title":"Melatonin induces Akt phosphorylation through melatonin receptor- and PI3K-dependent pathways in primary astrocytes","volume":"12","author":"Kong","year":"2008","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"34","key":"10.1016\/j.lfs.2019.05.009_bb1085","doi-asserted-by":"crossref","first-page":"56698","DOI":"10.18632\/oncotarget.18082","article-title":"Inhibition of the PI3K\/AKT\/mTOR pathway activates autophagy and compensatory Ras\/Raf\/MEK\/ERK signalling in prostate cancer","volume":"8","author":"Butler","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb1090","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.3892\/ol.2017.5785","article-title":"Melatonin treatment induces apoptosis through regulating the nuclear factor-kappaB and mitogen-activated protein kinase signaling pathways in human gastric cancer SGC7901 cells","volume":"13","author":"Li","year":"2017","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb1095","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3892\/or.2016.5100","article-title":"Melatonin induces cell apoptosis in Mia PaCa-2 cells via the suppression of nuclear factor-kappaB and activation of ERK and JNK: a novel therapeutic implication for pancreatic cancer","volume":"36","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb1100","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1159\/000438587","article-title":"Melatonin induces cell apoptosis in AGS cells through the activation of JNK and P38 MAPK and the suppression of nuclear factor-kappa B: a novel therapeutic implication for gastric cancer","volume":"37","author":"Li","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb1105","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12398","article-title":"Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK\/c-jun pathway in human hepatocellular carcinoma","volume":"62","author":"Lin","year":"2017","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb1110","doi-asserted-by":"crossref","first-page":"e2432","DOI":"10.1038\/cddis.2016.330","article-title":"Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway","volume":"7","author":"Lu","year":"2016","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb1115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.2002.20.4.973","article-title":"Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients","volume":"20","author":"Ferrandina","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.lfs.2019.05.009_bb1120","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/annonc\/mdf207","article-title":"Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients","volume":"13","author":"Ferrandina","year":"2002","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.lfs.2019.05.009_bb1125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10080251","article-title":"The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer","volume":"10","author":"Savant","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb1130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13048-018-0389-9","article-title":"Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors","volume":"11","author":"Beeghly-Fadiel","year":"2018","journal-title":"J. Ovarian Res."},{"issue":"8","key":"10.1016\/j.lfs.2019.05.009_bb1135","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/annonc\/mdf312","article-title":"Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled?","volume":"13","author":"Nasi","year":"2002","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.lfs.2019.05.009_bb1140","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00018-002-8518-3","article-title":"Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer","volume":"59","author":"Zaffaroni","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb1145","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3892\/ijo.2014.2300","article-title":"A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma","volume":"44","author":"Yusup","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"14","key":"10.1016\/j.lfs.2019.05.009_bb1150","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1158\/0008-5472.CAN-06-0325","article-title":"Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma","volume":"66","author":"Kern","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb1155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1158\/1535-7163.417.3.4","article-title":"Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2\/neu mice","volume":"3","author":"Lanza-Jacoby","year":"2004","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb1160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-079X.2012.00973.x","article-title":"Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells","volume":"53","author":"Wang","year":"2012","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb1165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/jpi.12217","article-title":"Melatonin-mediated Bim up-regulation and cyclooxygenase-2 (COX-2) down-regulation enhances tunicamycin-induced apoptosis in MDA-MB-231 cells","volume":"58","author":"Woo","year":"2015","journal-title":"J. Pineal Res."},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb1170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099943","article-title":"Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2\/iNOS and NF-\u03baB\/p300 signaling pathways","volume":"9","author":"Yi","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb1175","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jpi.12060","article-title":"Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting Survivin and XIAP","volume":"55","author":"Fan","year":"2013","journal-title":"J. Pineal Res."},{"issue":"1 Supplement","key":"10.1016\/j.lfs.2019.05.009_bb1180","doi-asserted-by":"crossref","first-page":"48.7","DOI":"10.4049\/jimmunol.188.Supp.48.7","article-title":"PI3K\/Akt pathway contributes to development of apoptosis resistance during differentiation of human macrophages by maintaining antiapoptotic Bcl-xL protein expression (48.7)","volume":"188","author":"Kumar","year":"2012","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2019.05.009_bb1185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039945","article-title":"Cross-talk between NFkB and the PI3-kinase\/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis","volume":"7","author":"Hussain","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.lfs.2019.05.009_bb1190","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/carcin\/bgm152","article-title":"Id-1 activation of PI3K\/Akt\/NF\u03baB signaling pathway and its significance in promoting survival of esophageal cancer cells","volume":"28","author":"Li","year":"2007","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb1195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40591-015-0041-7","article-title":"Cross talk of the first-line defense TLRs with PI3K\/Akt pathway, in preconditioning therapeutic approach","volume":"3","author":"Pourrajab","year":"2015","journal-title":"Mol. Cell. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb1200","first-page":"89","article-title":"Resistance to cisplatin-induced apoptosis via PI3K-dependent survivin expression in a rat hepatoma cell line","volume":"37","author":"Asechi","year":"2010","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb1205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1475-2867-13-36","article-title":"Targeting PI3K\/Akt represses hypoxia inducible factor-1\u03b1 activation and sensitizes rhabdomyosarcoma and Ewing's sarcoma cells for apoptosis","volume":"13","author":"Kilic-Eren","year":"2013","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.lfs.2019.05.009_bb1210","doi-asserted-by":"crossref","first-page":"e1437","DOI":"10.1038\/cddis.2014.415","article-title":"PI3K\/Akt\/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways","volume":"5","author":"Chang","year":"2014","journal-title":"Cell Death Dis."},{"issue":"68","key":"10.1016\/j.lfs.2019.05.009_bb1215","doi-asserted-by":"crossref","first-page":"112893","DOI":"10.18632\/oncotarget.22850","article-title":"Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2019.05.009_bb1220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/OTT.S89967","article-title":"PI3K inhibitors as new cancer therapeutics: implications for clinical trial design","volume":"9","author":"Massacesi","year":"2016","journal-title":"OncoTargets Therapy"},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb1225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.critrevonc.2015.07.005","article-title":"Targeting PI3K\/Akt\/mTOR signaling pathway in the treatment of prostate cancer radioresistance","volume":"96","author":"Chang","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"9","key":"10.1016\/j.lfs.2019.05.009_bb1230","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4155\/fmc.12.56","article-title":"Targeting the PI3K pathway for cancer therapy","volume":"4","author":"Sadeghi","year":"2012","journal-title":"Future Med. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2019.05.009_bb1235","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1158\/1078-0432.CCR-13-1607","article-title":"Inhibition of DNA double-strand break repair by the dual PI3K\/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma","volume":"20","author":"Gil del Alcazar","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb1240","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jpi.12060","article-title":"Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting survivin and XIAP","volume":"55","author":"Fan","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2019.05.009_bb1245","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.lfs.2019.05.009_bb1250","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.18632\/oncotarget.2037","article-title":"GSK-3 as potential target for therapeutic intervention in cancer","volume":"5","author":"McCubrey","year":"2014","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.lfs.2019.05.009_bb1255","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1073\/pnas.93.8.3636","article-title":"Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA","volume":"93","author":"Cheng","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb1260","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910640412","article-title":"Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas","volume":"64","author":"Bellacosa","year":"1995","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb1265","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/carcin\/23.1.201","article-title":"AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis","volume":"23","author":"Roy","year":"2002","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb1270","first-page":"25","article-title":"Akt2 expression correlates with prognosis of human hepatocellular carcinoma","volume":"11","author":"Xu","year":"2004","journal-title":"Oncol. Rep."},{"issue":"34","key":"10.1016\/j.lfs.2019.05.009_bb1275","doi-asserted-by":"crossref","first-page":"21342","DOI":"10.1039\/C7RA02113E","article-title":"Melatonin enhances the anti-tumor effect of sorafenib via AKT\/p27-mediated cell cycle arrest in hepatocarcinoma cell lines","volume":"7","author":"Long","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.lfs.2019.05.009_bb1280","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2147\/OTT.S82835","article-title":"Hypoxia-inducible factor-1\u03b1 induces multidrug resistance protein in colon cancer","volume":"8","author":"Lv","year":"2015","journal-title":"OncoTargets Therapy"},{"issue":"26","key":"10.1016\/j.lfs.2019.05.009_bb1285","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.2174\/0929867321666140414101056","article-title":"HIF-1 signaling in drug resistance to chemotherapy","volume":"21","author":"Warfel","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.lfs.2019.05.009_bb1290","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1002\/ijc.24601","article-title":"Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3","volume":"125","author":"Selvendiran","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb1295","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3390\/cancers6041986","article-title":"STAT3: a novel molecular mediator of resistance to Chemoradiotherapy","volume":"6","author":"Spitzner","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.lfs.2019.05.009_bb1300","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/ijc.30847","article-title":"Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma","volume":"141","author":"Bixel","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2019.05.009_bb1305","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4161\/cbt.10.4.12448","article-title":"Oxygenation inhibits ovarian tumor growth by downregulating STAT3 and cyclin-D1 expressions","volume":"10","author":"Selvendiran","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb1310","doi-asserted-by":"crossref","first-page":"216","DOI":"10.18632\/oncoscience.26","article-title":"Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor","volume":"1","author":"McCann","year":"2014","journal-title":"Oncoscience"},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb1315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbrc.2013.04.087","article-title":"Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells","volume":"435","author":"Han","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2019.05.009_bb1320","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/bbrc.2002.6421","article-title":"Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)","volume":"291","author":"Park","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.lfs.2019.05.009_bb1325","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1158\/0008-5472.CAN-04-0284","article-title":"Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation","volume":"64","author":"Kim","year":"2004","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.05.009_bb1330","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1871520615666150511094201","article-title":"Melatonin regulates angiogenic factors under hypoxia in breast cancer cell lines","volume":"16","author":"Jardim-Perassi","year":"2016","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb1335","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-079X.2009.00742.x","article-title":"Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia","volume":"48","author":"Park","year":"2010","journal-title":"J. Pineal Res."},{"issue":"9","key":"10.1016\/j.lfs.2019.05.009_bb1340","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2174\/1871520614666140812110246","article-title":"Molecular markers of angiogenesis and metastasis in lines of oral carcinoma after treatment with melatonin","volume":"14","author":"Goncalves Ndo","year":"2014","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.lfs.2019.05.009_bb1345","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.taap.2017.09.022","article-title":"Melatonin as an angiogenesis inhibitor to combat cancer: mechanistic evidence","volume":"335","author":"Goradel","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"7 Supplement","key":"10.1016\/j.lfs.2019.05.009_bb1350","first-page":"773","article-title":"Melatonin restores hypoxia-induced resistant to TRAIL-induced apoptosis","volume":"64","author":"Park","year":"2004","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.lfs.2019.05.009_bb1355","doi-asserted-by":"crossref","first-page":"11941","DOI":"10.3390\/ijms150711941","article-title":"Overcoming hypoxic-resistance of tumor cells to TRAIL-induced apoptosis through melatonin","volume":"15","author":"Lee","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.lfs.2019.05.009_bb1360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135420","article-title":"Melatonin cytotoxicity is associated to Warburg effect inhibition in Ewing sarcoma cells","volume":"10","author":"Sanchez-Sanchez","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.lfs.2019.05.009_bb1365","doi-asserted-by":"crossref","first-page":"23074","DOI":"10.3390\/ijms151223074","article-title":"Expression of the MT1 melatonin receptor in ovarian cancer cells","volume":"15","author":"Jablonska","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2019.05.009_bb1370","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409000982","article-title":"Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives","volume":"11","author":"Grant","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2019.05.009_bb1375","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jpi.12205","article-title":"Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair","volume":"58","author":"Alonso-Gonzalez","year":"2015","journal-title":"J. Pineal Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519303479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519303479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:23:24Z","timestamp":1758399804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519303479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":275,"alternative-id":["S0024320519303479"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.05.009","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}